Results analysis for the industry - healthcare services. Offers a bird's eye view of leader
stocks and laggard stocks, based on the performance for the quarter ending Mar 31, 2019.
Note: Industry-level growth metrics have been calculated by totaling the numbers of all
companies in that industry, to get an average.
| Stock | Growth | Mar-2019 (Rs Cr.) | Mar-2018 (Rs Cr.) |
|---|---|---|---|
| Aspira Pathlab & Diagnostics Ltd. | 41.0% | 2.1 | 1.5 |
| Dr. Lal Pathlabs Ltd. | 12.9% | 301.1 | 266.8 |
| Thyrocare Technologies Ltd. | 9.2% | 105.6 | 96.7 |
| Dr. Agarwal's Eye Hospital Ltd. | 9.2% | 41.0 | 37.6 |
| Vimta Labs Ltd. | 3.2% | 53.6 | 51.9 |
| Industry | Growth | This qtr | Prev qtr |
|---|---|---|---|
| Lasa Supergenerics Ltd. | -29.1% | 42.0 | 59.3 |
| Fortis Malar Hospitals Ltd. | -12.9% | 35.2 | 40.4 |
| Stock | Growth | Mar-2019 (Rs Cr.) | Mar-2018 (Rs Cr.) |
|---|---|---|---|
| Dr. Agarwal's Eye Hospital Ltd. | 287.3% | 1.6 | -0.8 |
| Lasa Supergenerics Ltd. | 72.2% | -1.8 | -6.5 |
| Vimta Labs Ltd. | 33.6% | 6.8 | 5.1 |
| Dr. Lal Pathlabs Ltd. | 17.9% | 47.4 | 40.2 |
| Aspira Pathlab & Diagnostics Ltd. | 9.3% | -1.2 | -1.4 |
| Industry | Growth | This qtr | Prev qtr |
|---|---|---|---|
| Fortis Malar Hospitals Ltd. | -62.0% | 0.5 | 1.2 |
| Thyrocare Technologies Ltd. | -35.3% | 16.3 | 25.1 |
| Stock | Growth | Mar-2019 (Rs Cr.) | Mar-2018 (Rs Cr.) |
|---|---|---|---|
| Lasa Supergenerics Ltd. | 639.3% | 3.1 | -0.6 |
| Dr. Agarwal's Eye Hospital Ltd. | 45.8% | 6.4 | 4.4 |
| Aspira Pathlab & Diagnostics Ltd. | 26.9% | -0.7 | -1.0 |
| Dr. Lal Pathlabs Ltd. | 3.4% | 66.2 | 64 |
| Vimta Labs Ltd. | 1.9% | 13.9 | 13.6 |
| Industry | Growth | This qtr | Prev qtr |
|---|---|---|---|
| Fortis Malar Hospitals Ltd. | -201.4% | -1.3 | 1.3 |
| Thyrocare Technologies Ltd. | -7.3% | 34.5 | 37.2 |
| Stock | Growth | Mar-2019 (Rs Cr.) | Mar-2018 (Rs Cr.) |
|---|---|---|---|
| Lasa Supergenerics Ltd. | 6419.0% | 4.3 | 0.1 |
| Dr. Agarwal's Eye Hospital Ltd. | 38.5% | 7.0 | 5.1 |
| Aspira Pathlab & Diagnostics Ltd. | 29.6% | -0.7 | -1.0 |
| Dr. Lal Pathlabs Ltd. | 9.3% | 79.7 | 72.9 |
| Vimta Labs Ltd. | 2.9% | 14.1 | 13.7 |
| Industry | Growth | This qtr | Prev qtr |
|---|---|---|---|
| Fortis Malar Hospitals Ltd. | -49.2% | 1.8 | 3.6 |
| Thyrocare Technologies Ltd. | -24.3% | 36.4 | 48.1 |
| Stock | Growth | Mar-2019 (%) | Mar-2018 (%) |
|---|---|---|---|
| Lasa Supergenerics Ltd. | 861.1% | 7.3 | -1.0 |
| Aspira Pathlab & Diagnostics Ltd. | 48.2% | -36.0 | -69.4 |
| Dr. Agarwal's Eye Hospital Ltd. | 33.5% | 15.7 | 11.8 |
| Industry | Growth | This qtr | Prev qtr |
|---|---|---|---|
| Fortis Malar Hospitals Ltd. | -216.5% | -3.8 | 3.3 |
| Thyrocare Technologies Ltd. | -15.2% | 32.7 | 38.5 |
| Dr. Lal Pathlabs Ltd. | -8.3% | 22.0 | 24.0 |
| Vimta Labs Ltd. | -1.2% | 25.9 | 26.2 |
| Stock | Revenue Qtr Cr | Revenue Growth Qtr YoY | Net Profit Qtr Cr | Net Profit Qtr Growth YoY % | Operating Profit Growth Qtr YoY % | EBIDT growth YoY % | Operating Profit Margin Growth YoY % | Last Result Updated |
|---|---|---|---|---|---|---|---|---|
| Vimta Labs Ltd. | 53.58 | 3.17 | 6.77 | 33.57 | 1.90 | 2.92 | -1.23 | 11-May-2019 |
| Dr. Lal Pathlabs Ltd. | 301.10 | 12.86 | 47.40 | 17.91 | 3.44 | 9.33 | -8.35 | 17-May-2019 |
| Thyrocare Technologies Ltd. | 105.59 | 9.24 | 16.25 | -35.34 | -7.34 | -24.25 | -15.18 | 20-May-2019 |
| Fortis Malar Hospitals Ltd. | 35.15 | -12.94 | 0.45 | -62.02 | -201.43 | -49.20 | -216.51 | 06-May-2019 |
| DRAGARWQ | 41.05 | 9.23 | 1.56 | 287.31 | 45.77 | 38.50 | 33.46 | 13-May-2019 |
| Lasa Supergenerics Ltd. | 42.02 | -29.15 | -1.80 | 72.19 | 639.28 | 6419.02 | 861.13 | 20-May-2019 |
| ASPIRA | 2.08 | 41.05 | -1.24 | 9.25 | 26.88 | 29.55 | 48.16 | 20-May-2019 |
